Oxana Beskrovnaya, Ph.D.Senior Vice President, Head of Research at Dyne Therapeutics
Oxana Beskrovnaya is an accomplished R&D leader with a strong track record of discovering and developing first-in-class therapeutics for rare genetic diseases. She is currently Senior Vice President and Head of Research at Dyne Therapeutics where she leads preclinical research focused on antibody-driven delivery of oligonucleotides for the treatment of serious muscle diseases. Prior to joining Dyne, she served as Head of musculoskeletal and renal research in Sanofi’s rare disease and neurological unit, where she advanced a pipeline of drug candidates using multiple therapeutic modalities, including nucleic acids, proteins and small molecules. Dr. Beskrovnaya is the author of numerous patents, invited reviews, editorials, book chapters and original research articles in major scientific journals. She received her Ph.D. in genetics from Moscow Genetics Institute, followed by postdoctoral fellowship training in neuromuscular diseases at the Howard Hughes Medical Institute at the University of Iowa.